zymeworks.com - ZYME Income before deduction of interest, taxes and amortization

Graphic logo of Zymeworks Inc (ZYME)

Zymeworks Inc. creates bispecific antibodies via the Azymetric system, effectively suppressing tumors. Demand for its immunotherapy remains stable regardless of market cycles. Cash operating profit clearly confirms financial stability, with the indicator value standing at 0.00. Experienced management ensures the business's success, maintaining the trust of global strategic partners.

Profit before payment of interest, taxes and amortization: Zymeworks Inc. (ZYME) for 11/23/2025 - 11/10/2026

Zymeworks - analytical breakdowns and key metrics (ZYME)

- market value and analyst target forecast:
Market Price Zymeworks Biopharmaceuticals|ZYME - Consensus Target
- issuer market value details:
Market Value Zymeworks|ZYME - Enterprise Value
- book capitalization information:
Net Assets per Share Zymeworks|ZYME - Company Book Value|Market Cap to Net Assets Ratio zymeworks.com|ZYME - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Zymeworks Inc.|ZYME - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Zymeworks Inc|ZYME - Company Debts|Debt to Book Value Ratio Zymeworks|ZYME - Company Long-Term Debt|Short-Term Debt Zymeworks|Critical Liquidity zymeworks.com
- company profitability and valuation multiples indicators:
ZYME - Net Income|Future Net Profit Zymeworks Inc.|ZYME - P/E Multiple|Future Price to Earnings Multiple zymeworks.com|ZYME - PEG Multiple|Company Value to EBITDA Zymeworks|ZYME - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Zymeworks|ZYME - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth zymeworks.com|ZYME - Earnings per share growth in current year|Net earnings per share change forecast for next year Zymeworks Inc.
Analysis of all company metrics:Zymeworks Biopharmaceuticals - ZYME
Mass-produced product of Zymeworks

This metric is calculated as the difference between operating income and expenses before taxes and depreciation. The metric determines the real cash efficiency of the business, excluding the impact of accounting distortions and debt load. For Zymeworks Inc. (ZYME), this volume is generated through royalties from pharma behemoths for access to its protein engineering platform. Analyzing the operating profit summary allows for the filtering of market noise. This chart's dynamics reveal the true phases of the company's fundamental growth.

Competitors of Zymeworks Inc. (ZYME)

NantKwest (IBRX) - Profit before interest, taxes and amortization|IMCR: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization JANX (januxrx.com)|RCUS: Operating profit EBITDA|TNGX - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Iovance|Operating profit before deduction of amortization Immatics Biotechnologies (IMTX)|Profit before payment of interest, taxes and amortization Xencor, Inc. (XNCR)|Operating profit before deduction of amortization compasstherapeutics.com CMPX|Replimune - Operating profit before deduction of amortization|Operating profit EBITDA Lyell LYEL|IPHA - Profit before payment of interest, taxes and amortization|PYXS (Pyxis Oncology, Inc.) - Operating profit before amortization|cgen.com (CGEN) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization iobiotech.com (IOBT)|Operating profit before deduction of amortization STRO|INKT - Operating profit before depreciation charges|Operating profit before deduction of amortization HOWL (Werewolf Therapeutics)|Company profit before taxes, interest and amortization IMMX|Operating profit EBITDA ALXO (ALX Oncology)|Income before deduction of interest, taxes and amortization CUE|PDS Biotechnology Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Profit before payment of interest, taxes and amortization|Liminatus - Income before deduction of interest, taxes and amortization|LVTX (LAVA Therapeutics NV) - Operating profit EBITDA|Operating profit EBITDA nextcure.com|Profit before payment of interest, taxes and amortization Leap Therapeutics, Inc. (LPTX)|INTS: Profit before deduction of interest, taxes, depreciation and amortization|Sensei Biotherapeutics, Inc. - Operating profit before deduction of amortization|Theriva Corp (TOVX) - Profit before interest, taxes and amortization|GRTS: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization KA|NEXI (NexImmune) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization Turnstone Biologics Corp. (TSBX)|Profit before payment of interest, taxes and amortization Vaccinex, Inc|Operating profit before deduction of amortization Harpoon Therapeutics Corp (HARP)